Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
116 Leser
Artikel bewerten:
(0)

Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry

NEW YORK, Oct. 17, 2011 /PRNewswire/ -- Berkery Noyes, the leading independent investment bank specializing in the information content and technology industries, today released its Third Quarter 2011 Mergers and Acquisitions Update for the Pharma and Healthcare Information and Technology Industry.

The report analyzes merger and acquisition activity over the first three quarters of 2011 and compares it with activity in 2010. This market includes information and technology companies servicing pharma, healthcare payer and healthcare provider spaces.

According to Berkery Noyes research, the report showed third quarter transaction volume decreased 6 percent over the previous period. However, transaction value increased 245 percent in the third quarter. This sharp increase can be explained by Blackstone Group's announced third quarter acquisition of Emdeon for $3.03 billion, the largest transaction thus far in 2011.

Median EBITDA multiples from 2010 to the first nine months of 2011 went from 11.8 to 10.8, an 8 percent decrease, while median revenue multiples decreased from 2.0 to 1.8, a 10 percent decline.

The most active acquirer through the third quarter was PerkinElmer with four acquisitions: Labtronics, Geospiza, CambridgeSoft, and ArtusLabs.

"PerkinElmer has demonstrated the vast potential for informatics and software integration into laboratory environments," said managing director Jeffrey Smith. "The need to integrate scientific tools, effectively manage knowledge, and organize workflow within laboratory settings is becoming even more crucial for clients of organizations such as PerkinElmer."

Berkery Noyes specializes in Mergers & Acquisitions advisory services, in addition to structuring debt and equity transactions in the $25 million to $500 million range. Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and more current information. The firm's research teams publish acquisition activity in the respective sectors they follow on MandAsoft.com.

A copy of the THIRD QUARTER 2011 PHARMA AND HEALTHCARE INFORMATION AND TECHNOLOGY INDUSTRY MERGERS & ACQUISITIONS UPDATE is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve the personal and professional objectives. For more information, visit www.berkerynoyes.com.

Contact Information:
Katie Weathers
www.csg-pr.com
404-791-8245
kweathers@csg-pr.com

SOURCE Berkery Noyes

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.